Filing metadata

Accession number
0000950170-24-041300
Form type
Form 4
Filer
Inozyme Pharma, Inc.
CIK
CIK 1693011
Filed
Apr 03, 2024
Reporting period
Mar 28, 2024
Description
Insider transaction

Explore SEC Filings Hub